News and Announcements
4Dx 2016 Retail Investment Round Fully Subscribed
- Published September 08, 2016 4:31PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
4Dx Limited is pleased to announce that our initial retail offering closed on the 31st August 2016, fully subscribed. The company has been overwhelmed with the level of interest in our world-first technology and take this opportunity to thank everyone who has expressed interest in 4Dx, and welcome all new shareholders to the 4Dx Group.
ABOUT 4DX
4Dx brings a technological solution set to disrupt this multi-billion dollar sector through compelling unique competitive advantages over existing respiratory diagnostics. The respiratory diagnostic sector represents a global market of over $25B perannum. Currently served by out of date technology, 4Dx has enormous scope for financial success as well as life changing advancement for medicine.
Offering more detailed information, faster validation of treatment efficacy, lower costs, and reduced radiation dosage, 4Dx allows for earlier detection of disease and earlier intervention.The ability to identify lung issues earlier is creating a critical shift in the practice model from cure to prevention.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
